Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPROPION Cause Product quality issue? 417 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 417 reports of Product quality issue have been filed in association with BUPROPION (Bupropion Hydrochloride (XL)). This represents 1.2% of all adverse event reports for BUPROPION.

417
Reports of Product quality issue with BUPROPION
1.2%
of all BUPROPION reports
3
Deaths
18
Hospitalizations

How Dangerous Is Product quality issue From BUPROPION?

Of the 417 reports, 3 (0.7%) resulted in death, 18 (4.3%) required hospitalization, and 9 (2.2%) were considered life-threatening.

Is Product quality issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPROPION. However, 417 reports have been filed with the FAERS database.

What Other Side Effects Does BUPROPION Cause?

Completed suicide (5,095) Drug ineffective (3,991) Toxicity to various agents (3,837) Depression (2,486) Overdose (2,357) Headache (2,323) Anxiety (2,145) Intentional overdose (2,103) Drug hypersensitivity (1,967) Seizure (1,894)

What Other Drugs Cause Product quality issue?

ETONOGESTREL (4,651) ALBUTEROL (4,466) TIOTROPIUM (3,821) MOMETASONE FUROATE (3,406) LIDOCAINE (3,126) FLUTICASONE\SALMETEROL (2,986) FORMOTEROL\MOMETASONE FUROATE (2,458) FENTANYL (2,450) NICOTINE (1,987) EXENATIDE (1,839)

Which BUPROPION Alternatives Have Lower Product quality issue Risk?

BUPROPION vs BUPROPION HYDROBROMIDE BUPROPION vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPROPION vs BUPROPION\NALTREXONE BUPROPION vs BUROSUMAB BUPROPION vs BUROSUMAB-TWZA

Related Pages

BUPROPION Full Profile All Product quality issue Reports All Drugs Causing Product quality issue BUPROPION Demographics